Rathnayake U, Wada J, Wall V, Jones J, Jenkins L, Andreotti A
Protein Expr Purif. 2025; 229:106682.
PMID: 39894064
PMC: 11875054.
DOI: 10.1016/j.pep.2025.106682.
Fresa A, Innocenti I, Tomasso A, Stirparo L, Mosca A, Iadevaia F
Ther Adv Hematol. 2024; 15:20406207241282570.
PMID: 39534542
PMC: 11555748.
DOI: 10.1177/20406207241282570.
He T, Huang J, Peng B, Wang M, Shui Q, Cai L
Am J Transl Res. 2024; 16(3):755-767.
PMID: 38586100
PMC: 10994811.
DOI: 10.62347/MTAY7931.
Liu X, Chen L, Peng W, Deng H, Ni H, Tong H
Front Immunol. 2024; 15:1356869.
PMID: 38558800
PMC: 10978743.
DOI: 10.3389/fimmu.2024.1356869.
Passeron T, King B, Seneschal J, Steinhoff M, Jabbari A, Ohyama M
Front Immunol. 2023; 14:1243556.
PMID: 38022501
PMC: 10657858.
DOI: 10.3389/fimmu.2023.1243556.
Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma.
Toyoda H, Tani A, Goto-Koshino Y, Motegi T, Sakamoto M, Mochizuki T
J Vet Med Sci. 2023; 86(1):18-27.
PMID: 37952972
PMC: 10849849.
DOI: 10.1292/jvms.23-0269.
Systematic analysis of various RNA transcripts and construction of biological regulatory networks at the post-transcriptional level for chronic obstructive pulmonary disease.
Li B, Zhang J, Dong H, Feng X, Yu L, Zhu J
J Transl Med. 2023; 21(1):790.
PMID: 37936118
PMC: 10631086.
DOI: 10.1186/s12967-023-04674-7.
Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition.
Zhao M, Li L, Kiernan C, Castro Eiro M, Dammeijer F, van Meurs M
Sci Rep. 2023; 13(1):15678.
PMID: 37735204
PMC: 10514027.
DOI: 10.1038/s41598-023-42871-y.
Lytic granule exocytosis at immune synapses: lessons from neuronal synapses.
Chang H, Schirra C, Pattu V, Krause E, Becherer U
Front Immunol. 2023; 14:1177670.
PMID: 37275872
PMC: 10233144.
DOI: 10.3389/fimmu.2023.1177670.
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Nikitin E, Kislova M, Morozov D, Belyakova V, Suvorova A, Sveshnikova J
Leukemia. 2023; 37(7):1464-1473.
PMID: 37202442
PMC: 10195665.
DOI: 10.1038/s41375-023-01891-3.
Protein kinases: drug targets for immunological disorders.
Castelo-Soccio L, Kim H, Gadina M, Schwartzberg P, Laurence A, OShea J
Nat Rev Immunol. 2023; 23(12):787-806.
PMID: 37188939
PMC: 10184645.
DOI: 10.1038/s41577-023-00877-7.
Inhibition of ITK Signaling Causes Amelioration in Sepsis-Associated Neuroinflammation and Depression-like State in Mice.
Algahtani M, Alshehri S, Alqarni S, Ahmad S, Al-Harbi N, Alqarni S
Int J Mol Sci. 2023; 24(9).
PMID: 37175808
PMC: 10179574.
DOI: 10.3390/ijms24098101.
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
Jiang B, Weinstock D, Donovan K, Sun H, Wolfe A, Amaka S
Cell Chem Biol. 2023; 30(4):383-393.e6.
PMID: 37015223
PMC: 10151063.
DOI: 10.1016/j.chembiol.2023.03.007.
ASK120067 potently suppresses B-cell or T-cell malignancies and by inhibiting BTK and ITK.
Song P, Bai G, Chan S, Zhang T, Tong L, Su Y
Front Pharmacol. 2023; 13:1071114.
PMID: 36588692
PMC: 9799096.
DOI: 10.3389/fphar.2022.1071114.
The combination of SMRT sequencing and Illumina sequencing highlights organ-specific and age-specific expression patterns of miRNAs in Sika Deer.
Jia B, Wang X, Ma F, Li X, Han X, Zhang L
Front Vet Sci. 2022; 9:1042445.
PMID: 36452144
PMC: 9701854.
DOI: 10.3389/fvets.2022.1042445.
Editorial: Further advances in understanding the endocrine cancer microenvironment.
Coperchini F, Melillo R, Rotondi M
Front Endocrinol (Lausanne). 2022; 13:1009963.
PMID: 36093100
PMC: 9449897.
DOI: 10.3389/fendo.2022.1009963.
Immunogenicity of SARS-CoV-2 vaccines in patients with cancer.
Kakkassery H, Carpenter E, Patten P, Irshad S
Trends Mol Med. 2022; 28(12):1082-1099.
PMID: 35999131
PMC: 9345889.
DOI: 10.1016/j.molmed.2022.07.006.
MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
Choi Y, Kim C, Choi E, Lee S, Chae M, Jun H
PLoS One. 2022; 17(8):e0270416.
PMID: 35980936
PMC: 9387810.
DOI: 10.1371/journal.pone.0270416.
Combination Approaches to Target PD-1 Signaling in Cancer.
Moore E, Strazza M, Mor A
Front Immunol. 2022; 13:927265.
PMID: 35911672
PMC: 9330480.
DOI: 10.3389/fimmu.2022.927265.
Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma.
Jiang Y, Sun H, Xu H, Hu X, Wu W, Lv Y
Front Genet. 2022; 13:872001.
PMID: 35754837
PMC: 9214219.
DOI: 10.3389/fgene.2022.872001.